Showing results (81-90 of 370) with videos related to
Sort By:
Pageof 37
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1993
The use of platelets as models for neurons: possible applications to the investigation of eating disordersM A Barradas, D P MikhailidisCurrent Medical Research and Opinion|July 14, 2000
HDL-cholesterol and the treatment of coronary heart disease: contrasting effects of atorvastatin and simvastatinD P Mikhailidis, A S WierzbickiPlatelets|August 12, 2000
An investigation of the serotonergic effects of fenfluramine, dexfenfluramine and dexnorfenfluramine using platelets as neuronal modelsI A Jagroop, D P MikhailidisPlatelets|October 13, 2000
Effect of endothelin-1 on human platelet shape change: reversal of activation by naftidrofurylI A Jagroop, D P MikhailidisJournal of Human Hypertension|September 12, 2000
Angiotensin II can induce and potentiate shape change in human platelets: effect of losartanI A Jagroop, D P MikhailidisProstaglandins, Leukotrienes, and Essential Fatty Acids|October 1, 1990
Platelet-activating factor (PAF) and its relation to prostaglandins, leukotrienes and other aspects of arachidonate metabolismP V Peplow, D P MikhailidisBJU International|October 6, 1999
The interaction of homocysteine and copper markedly inhibits the relaxation of rabbit corpus cavernosum: new risk factors for angiopathic erectile dysfunction?M A Khan, C S Thompson, A M Emsley, et al.Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|January 1, 1992
Serotonin, histamine and platelets in vascular disease with special reference to peripheral vascular diseaseM A Barradas, D P MikhailidisJournal of Human Hypertension|April 24, 2001
Doxazosin, an alpha1-adrenoceptor antagonist, inhibits serotonin-induced shape change in human plateletsI A Jagroop, D P MikhailidisCurrent Pharmaceutical Design|February 10, 2009
Lipid-lowering drugs acting at the level of the gastrointestinal tractT D Filippatos, D P MikhailidisPageof 37